Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine.

[1]  Kathryn A. Yamada,et al.  Human induced pluripotent stem cell-derived cardiomyocytes , 2017 .

[2]  Praveen Shukla,et al.  Engineered heart tissues and induced pluripotent stem cells: Macro- and microstructures for disease modeling, drug screening, and translational studies. , 2016, Advanced drug delivery reviews.

[3]  P. Burridge,et al.  Genetic and Epigenetic Regulation of Human Cardiac Reprogramming and Differentiation in Regenerative Medicine. , 2015, Annual review of genetics.

[4]  J. Rinn,et al.  A comparison of genetically matched cell lines reveals the equivalence of human iPSCs and ESCs , 2015, Nature Biotechnology.

[5]  Christine L. Mummery,et al.  Contractile Defect Caused by Mutation in MYBPC3 Revealed under Conditions Optimized for Human PSC-Cardiomyocyte Function , 2015, Cell reports.

[6]  P. Burridge,et al.  Chemically Defined Culture and Cardiomyocyte Differentiation of Human Pluripotent Stem Cells , 2015, Current protocols in human genetics.

[7]  Robert Lanza,et al.  Current status of pluripotent stem cells: moving the first therapies to the clinic , 2015, Nature Reviews Drug Discovery.

[8]  Malte Tiburcy,et al.  Human Engineered Heart Muscles Engraft and Survive Long Term in a Rodent Myocardial Infarction Model. , 2015, Circulation research.

[9]  A. Hagège,et al.  Long-term functional benefits of human embryonic stem cell-derived cardiac progenitors embedded into a fibrin scaffold. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[10]  George Church,et al.  Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy , 2015, Science.

[11]  E. Tartour,et al.  Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report. , 2015, European heart journal.

[12]  I. Y. Chen,et al.  Reprogramming and transdifferentiation for cardiovascular development and regenerative medicine: where do we stand? , 2015, EMBO molecular medicine.

[13]  Y. Eto,et al.  Disease modeling and lentiviral gene transfer in patient-specific induced pluripotent stem cells from late-onset Pompe disease patient , 2015, Molecular therapy. Methods & clinical development.

[14]  Michael Eldar,et al.  Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations , 2015, Journal of cellular and molecular medicine.

[15]  Donald M Bers,et al.  Epigenetic Regulation of Phosphodiesterases 2A and 3A Underlies Compromised β-Adrenergic Signaling in an iPSC Model of Dilated Cardiomyopathy. , 2015, Cell stem cell.

[16]  Larry A Couture,et al.  Hurdles to clinical translation of human induced pluripotent stem cells. , 2015, The Journal of clinical investigation.

[17]  I. Karakikes,et al.  Induced Pluripotent Stem Cell–Derived Cardiomyocytes: A New and Versatile Human In Vitro Cardiomyocyte Model Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes Insights Into Molecular, Cellular, and Functional Phenotypes , 2015 .

[18]  Philip T Sager,et al.  Finding the rhythm of sudden cardiac death: new opportunities using induced pluripotent stem cell-derived cardiomyocytes. , 2015, Circulation research.

[19]  Kavitha T. Kuppusamy,et al.  Let-7 family of microRNA is required for maturation and adult-like metabolism in stem cell-derived cardiomyocytes , 2015, Proceedings of the National Academy of Sciences.

[20]  G. Bett,et al.  Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy , 2015, Development.

[21]  Ronald A. Li,et al.  Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy , 2015, Nature Communications.

[22]  Joseph C. Wu,et al.  Induced pluripotent stem cells. , 2015, JAMA.

[23]  Luke P. Lee,et al.  Human iPSC-based Cardiac Microphysiological System For Drug Screening Applications , 2015, Scientific Reports.

[24]  F. Collins,et al.  A new initiative on precision medicine. , 2015, The New England journal of medicine.

[25]  Robert Passier,et al.  Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology , 2015, EMBO molecular medicine.

[26]  Randall J. Platt,et al.  Therapeutic genome editing: prospects and challenges , 2015, Nature Medicine.

[27]  Simona Casini,et al.  Immaturity of human stem-cell-derived cardiomyocytes in culture: fatal flaw or soluble problem? , 2015, Stem cells and development.

[28]  Bruce J. Aronow,et al.  Transdifferentiation of Human Fibroblasts to Endothelial Cells: Role of Innate Immunity , 2013, Circulation.

[29]  Ying Ge,et al.  Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells. , 2014, Cell stem cell.

[30]  K. Kolaja,et al.  Disease modeling and phenotypic drug screening for diabetic cardiomyopathy using human induced pluripotent stem cells. , 2014, Cell reports.

[31]  H. Calkins,et al.  Erratum: "Identification of a New Modulator of the Intercalated Disc in a Zebrafish Model of Arrhythmogenic Cardiomyopathy" (Science Translational Medicine (2014) 6:261 (261er6)) , 2014 .

[32]  C. Murry,et al.  Letter by Murry et al regarding article, "Embryonic stem cell-derived cardiac myocytes are not ready for human trials". , 2014, Circulation research.

[33]  V. Beneš,et al.  Dynamic DNA methylation orchestrates cardiomyocyte development, maturation and disease , 2014, Nature Communications.

[34]  Chris Denning,et al.  Aberrant α-Adrenergic Hypertrophic Response in Cardiomyocytes from Human Induced Pluripotent Cells , 2014, Stem cell reports.

[35]  D. Arnett,et al.  RNA Expression Profiling of Human iPSC-Derived Cardiomyocytes in a Cardiac Hypertrophy Model , 2014, PloS one.

[36]  P. Burridge,et al.  Characterization of the molecular mechanisms underlying increased ischemic damage in the aldehyde dehydrogenase 2 genetic polymorphism using a human induced pluripotent stem cell model system , 2014, Science Translational Medicine.

[37]  A. Gillich,et al.  Cardiac Tissue Slice Transplantation as a Model to Assess Tissue-Engineered Graft Thickness, Survival, and Function , 2014, Circulation.

[38]  M. Kyba,et al.  Acquisition of a Quantitative, Stoichiometrically Conserved Ratiometric Marker of Maturation Status in Stem Cell-Derived Cardiac Myocytes , 2014, Stem cell reports.

[39]  K. Red-Horse,et al.  Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes as an In Vitro Model for Coxsackievirus B3–Induced Myocarditis and Antiviral Drug Screening Platform , 2014, Circulation research.

[40]  M. Kay,et al.  Genome editing of isogenic human induced pluripotent stem cells recapitulates long QT phenotype for drug testing. , 2014, Journal of the American College of Cardiology.

[41]  D. Atsma,et al.  Cardiac anisotropy, regeneration, and rhythm. , 2014, Circulation Research.

[42]  Praveen Shukla,et al.  Chemically defined generation of human cardiomyocytes , 2014, Nature Methods.

[43]  S. Houser,et al.  Embryonic stem cell-derived cardiac myocytes are not ready for human trials. , 2014, Circulation research.

[44]  H. Calkins,et al.  Identification of a New Modulator of the Intercalated Disc in a Zebrafish Model of Arrhythmogenic Cardiomyopathy , 2014, Science Translational Medicine.

[45]  Paul W. Burridge,et al.  Human Stem Cells for Modeling Heart Disease and for Drug Discovery , 2014, Science Translational Medicine.

[46]  George A. Truskey,et al.  Modeling the mitochondrial cardiomyopathy of Barth syndrome with iPSC and heart-on-chip technologies , 2014, Nature Medicine.

[47]  H. Kim,et al.  A guide to genome engineering with programmable nucleases , 2014, Nature Reviews Genetics.

[48]  Charles E. Murry,et al.  Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate Non-Human Primate Hearts , 2014, Nature.

[49]  T. V. van Veen,et al.  Assembly of the Cardiac Intercalated Disk during Pre- and Postnatal Development of the Human Heart , 2014, PloS one.

[50]  Shinya Yamanaka,et al.  iPS cells: a game changer for future medicine , 2014, The EMBO journal.

[51]  M. LeWinter,et al.  Cardiac Titin and Heart Disease , 2014, Journal of cardiovascular pharmacology.

[52]  Lil Pabon,et al.  Engineering Adolescence: Maturation of Human Pluripotent Stem Cell–Derived Cardiomyocytes , 2014, Circulation research.

[53]  Ronald A. Li,et al.  Developmental cues for the maturation of metabolic, electrophysiological and calcium handling properties of human pluripotent stem cell-derived cardiomyocytes , 2014, Stem Cell Research & Therapy.

[54]  Junichi Kiryu,et al.  Characterization of Human Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium Cell Sheets Aiming for Clinical Application , 2014, Stem cell reports.

[55]  Joseph C. Wu,et al.  Cardiac Stem Cell Biology: Glimpse of the Past, Present, and Future , 2014, Circulation research.

[56]  F. Gleason,et al.  Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA , 2014 .

[57]  Modeling of Friedreich ataxia-related iron overloading cardiomyopathy using patient-specific-induced pluripotent stem cells , 2014, Pflügers Archiv - European Journal of Physiology.

[58]  H. Okano,et al.  The use of induced pluripotent stem cells to reveal pathogenic gene mutations and explore treatments for retinitis pigmentosa , 2014, Molecular Brain.

[59]  Joseph C. Wu,et al.  Patient-specific stem cells and cardiovascular drug discovery. , 2013, JAMA.

[60]  Simona Casini,et al.  Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome , 2013, The EMBO journal.

[61]  Teng Hong Tan,et al.  Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells. , 2013, International journal of cardiology.

[62]  Zohar Mukamel,et al.  Deterministic direct reprogramming of somatic cells to pluripotency , 2013, Nature.

[63]  J. Cooke,et al.  Therapeutic transdifferentiation: can we generate cardiac tissue rather than scar after myocardial injury? , 2013, Methodist DeBakey cardiovascular journal.

[64]  Xu Xiaoping,et al.  Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotype. , 2013, American journal of physiology. Heart and circulatory physiology.

[65]  L. Ye,et al.  Patching the Heart: Cardiac Repair From Within and Outside , 2013, Circulation research.

[66]  Donald M Bers,et al.  Screening Drug-Induced Arrhythmia Using Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes and Low-Impedance Microelectrode Arrays , 2013, Circulation.

[67]  H. Deng,et al.  Pluripotent Stem Cells Induced from Mouse Somatic Cells by Small-Molecule Compounds , 2013, Science.

[68]  Wei-Zhong Zhu,et al.  Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. , 2013, Stem cells and development.

[69]  H. Nakauchi,et al.  Generation of engraftable hematopoietic stem cells from induced pluripotent stem cells by way of teratoma formation. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[70]  Michael Xavier Doss,et al.  Identification and characterization of a transient outward K+ current in human induced pluripotent stem cell-derived cardiomyocytes. , 2013, Journal of molecular and cellular cardiology.

[71]  Nenad Bursac,et al.  Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes. , 2013, Biomaterials.

[72]  K. Eggan,et al.  Modeling human disease with pluripotent stem cells: from genome association to function. , 2013, Cell stem cell.

[73]  Donald M Bers,et al.  Drug Screening Using a Library of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes Reveals Disease-Specific Patterns of Cardiotoxicity , 2013, Circulation.

[74]  P. Sham,et al.  Patient-specific induced-pluripotent stem cells-derived cardiomyocytes recapitulate the pathogenic phenotypes of dilated cardiomyopathy due to a novel DES mutation identified by whole exome sequencing. , 2013, Human molecular genetics.

[75]  L. Ye,et al.  Functional Consequences of Human Induced Pluripotent Stem Cell Therapy: Myocardial ATP Turnover Rate in the In Vivo Swine Heart With Postinfarction Remodeling , 2013, Circulation.

[76]  Sanjay Kumar.  Microtubule assembly: Switched on with magnets. , 2013, Nature nanotechnology.

[77]  Tory M. Schaaf,et al.  An ex vivo Gene Therapy Approach to Treat Muscular Dystrophy Using inducible Pluripotent Stem Cells , 2013, Nature Communications.

[78]  Harris H. Wang,et al.  Genome-scale engineering for systems and synthetic biology , 2013, Molecular systems biology.

[79]  Dionne A. Graham,et al.  Cardiomyocyte proliferation contributes to heart growth in young humans , 2013, Proceedings of the National Academy of Sciences.

[80]  Euan A Ashley,et al.  Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. , 2013, Cell stem cell.

[81]  H. Calkins,et al.  Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs , 2012, Nature.

[82]  Divya Rajamohan,et al.  Current status of drug screening and disease modelling in human pluripotent stem cells , 2012, BioEssays : news and reviews in molecular, cellular and developmental biology.

[83]  江頭 徹.  Disease characterization using LQTS-specific induced pluripotent stem cells , 2013 .

[84]  Sean P. Palecek,et al.  Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions , 2012, Nature Protocols.

[85]  S. Ramaswamy,et al.  A Molecular Roadmap of Reprogramming Somatic Cells into iPS Cells , 2012, Cell.

[86]  S. Tsang,et al.  3 1 2 | L I E T a L . | M O L M E D 1 8 : 1 3 1 2 -1 3 1 9 , 2 0 1 2 , 2022 .

[87]  C. Siu,et al.  Modeling of lamin A/C mutation premature cardiac aging using patient-specific induced pluripotent stem cells , 2012, Aging.

[88]  W. Wong,et al.  Activation of Innate Immunity Is Required for Efficient Nuclear Reprogramming , 2012, Cell.

[89]  Sandy L. Klemm,et al.  Single-Cell Expression Analyses during Cellular Reprogramming Reveal an Early Stochastic and a Late Hierarchic Phase , 2012, Cell.

[90]  Jiannis Ragoussis,et al.  Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels , 2012, Proceedings of the National Academy of Sciences.

[91]  L. Ye,et al.  Bioenergetic and Functional Consequences of Cellular Therapy: Activation of Endogenous Cardiovascular Progenitor Cells , 2012, Circulation research.

[92]  C. Mummery,et al.  Cardiomyocytes Derived From Pluripotent Stem Cells Recapitulate Electrophysiological Characteristics of an Overlap Syndrome of Cardiac Sodium Channel Disease , 2012, Circulation.

[93]  David Milan,et al.  Inefficient Reprogramming of Fibroblasts into Cardiomyocytes Using Gata4, Mef2c, and Tbx5 , 2012, Circulation research.

[94]  Atsushi Izawa,et al.  hESC-Derived Cardiomyocytes Electrically Couple and Suppress Arrhythmias in Injured Hearts , 2012, Nature.

[95]  Peter Kohl,et al.  Simultaneous Voltage and Calcium Mapping of Genetically Purified Human Induced Pluripotent Stem Cell–Derived Cardiac Myocyte Monolayers , 2012, Circulation research.

[96]  Euan A. Ashley,et al.  Patient-Specific Induced Pluripotent Stem Cells as a Model for Familial Dilated Cardiomyopathy , 2012, Science Translational Medicine.

[97]  Laura Iop,et al.  Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia , 2012, EMBO molecular medicine.

[98]  Ofer Binah,et al.  Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to β-adrenergic stimulation , 2012, Journal of cellular and molecular medicine.

[99]  Jane Synnergren,et al.  Global transcriptional profiling reveals similarities and differences between human stem cell-derived cardiomyocyte clusters and heart tissue. , 2012, Physiological genomics.

[100]  W. Bloch,et al.  Contractile properties of early human embryonic stem cell-derived cardiomyocytes: beta-adrenergic stimulation induces positive chronotropy and lusitropy but not inotropy. , 2012, Stem cells and development.

[101]  Gordon Keller,et al.  Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. , 2012, Cell stem cell.

[102]  P. Stork,et al.  Thyroid hormone drives fetal cardiomyocyte maturation , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[103]  Katriina Aalto-Setälä,et al.  Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture , 2011, Disease Models & Mechanisms.

[104]  Deborah K. Lieu,et al.  Distinct Roles of MicroRNA-1 and -499 in Ventricular Specification and Functional Maturation of Human Embryonic Stem Cell-Derived Cardiomyocytes , 2011, PloS one.

[105]  James A Thomson,et al.  High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents. , 2011, American journal of physiology. Heart and circulatory physiology.

[106]  H. Okano,et al.  Grafted human-induced pluripotent stem-cell–derived neurospheres promote motor functional recovery after spinal cord injury in mice , 2011, Proceedings of the National Academy of Sciences.

[107]  Liang Guo,et al.  Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[108]  L. Hui,et al.  Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors , 2011, Nature.

[109]  Charles E. Murry,et al.  Growth of Engineered Human Myocardium With Mechanical Loading and Vascular Coculture , 2011, Circulation research.

[110]  L. Marchionni,et al.  In Vivo Liver Regeneration Potential of Human Induced Pluripotent Stem Cells from Diverse Origins , 2011, Science Translational Medicine.

[111]  K. Narsinh,et al.  Derivation of Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling , 2011, Circulation research.

[112]  Jackie Schiller,et al.  Calcium Handling in Human Induced Pluripotent Stem Cell Derived Cardiomyocytes , 2011, PloS one.

[113]  Jonathan A. Bernstein,et al.  Using iPS cells to investigate cardiac phenotypes in patients with Timothy Syndrome , 2011, Nature.

[114]  Lior Gepstein,et al.  Modelling the long QT syndrome with induced pluripotent stem cells , 2011, Nature.

[115]  Divya Rajamohan,et al.  Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation , 2011, European heart journal.

[116]  Michael J. Ziller,et al.  Reference Maps of Human ES and iPS Cell Variation Enable High-Throughput Characterization of Pluripotent Cell Lines , 2011, Cell.

[117]  Pengyuan Zhang,et al.  A Fibrin Patch‐Based Enhanced Delivery of Human Embryonic Stem Cell‐Derived Vascular Cell Transplantation in a Porcine Model of Postinfarction Left Ventricular Remodeling , 2011, Stem cells.

[118]  Julia Gorelik,et al.  Modulation of human embryonic stem cell-derived cardiomyocyte growth: A testbed for studying human cardiac hypertrophy? , 2011, Journal of molecular and cellular cardiology.

[119]  J. Gold,et al.  Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats. , 2010, Journal of molecular and cellular cardiology.

[120]  Alexander Meissner,et al.  Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. , 2010, Cell stem cell.

[121]  Karl-Ludwig Laugwitz,et al.  Patient-specific induced pluripotent stem-cell models for long-QT syndrome. , 2010, New England Journal of Medicine.

[122]  Ronald A. Li,et al.  Dynamic MicroRNA Expression Programs During Cardiac Differentiation of Human Embryonic Stem Cells: Role for miR-499 , 2010, Circulation. Cardiovascular genetics.

[123]  Aaron M. Newman,et al.  Lab-specific gene expression signatures in pluripotent stem cells. , 2010, Cell stem cell.

[124]  Richard A Young,et al.  Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. , 2010, Cell stem cell.

[125]  G. Daley,et al.  Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. , 2010, Cell stem cell.

[126]  M. Vos,et al.  Quantified proarrhythmic potential of selected human embryonic stem cell-derived cardiomyocytes. , 2010, Stem cell research.

[127]  F. Gage,et al.  Pluripotent stem cells in neurodegenerative and neurodevelopmental diseases. , 2010, Human molecular genetics.

[128]  Lei Yang,et al.  Patient-specific induced pluripotent stem cell derived models of LEOPARD syndrome , 2010, Nature.

[129]  Robert Passier,et al.  Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. , 2010, Stem cell research.

[130]  Deepak M. Gupta,et al.  A nonviral minicircle vector for deriving human iPS cells , 2010, Nature Methods.

[131]  T. Quertermous,et al.  Persistent Donor Cell Gene Expression among Human Induced Pluripotent Stem Cells Contributes to Differences with Human Embryonic Stem Cells , 2010, PloS one.

[132]  Thomas Vierbuchen,et al.  Direct conversion of fibroblasts to functional neurons by defined factors , 2010, Nature.

[133]  Y. FNi,et al.  Comparison of Potentials of Stem Cells Isolated from Tendon and Bone Marrow for Musculoskeletal Tissue Engineering , 2010 .

[134]  Masaki Ieda,et al.  Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. , 2010, Cell.

[135]  Deepak M. Gupta,et al.  Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells , 2009, Proceedings of the National Academy of Sciences.

[136]  Jianyi(Jay) Zhang,et al.  Stem Cells for Myocardial Repair With Use of a Transarterial Catheter , 2009, Circulation.

[137]  Robert Lanza,et al.  EMBRYONIC STEM CELLS / INDUCED PLURIPOTENT STEM CELLS Long-Term Safety and Function of RPE from Human Embryonic Stem Cells in Preclinical Models of Macular Degeneration , 2009 .

[138]  Mike J. Mason,et al.  Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. , 2009, Cell stem cell.

[139]  A. Consiglio,et al.  Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells , 2009, Nature.

[140]  Dong Wook Han,et al.  Generation of induced pluripotent stem cells using recombinant proteins. , 2009, Cell stem cell.

[141]  Wei Wang,et al.  piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells , 2009, Nature.

[142]  P. Kirshbom,et al.  Force Frequency Relationship of the Human Ventricle Increases During Early Postnatal Development , 2009, Pediatric Research.

[143]  G. Daley,et al.  Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming , 2009, Nature Biotechnology.

[144]  Sean P. Palecek,et al.  Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells , 2009, Circulation research.

[145]  R. Jaenisch,et al.  Reprogramming of murine and human somatic cells using a single polycistronic vector , 2009, Proceedings of the National Academy of Sciences.

[146]  Xiaolei Yin,et al.  Two supporting factors greatly improve the efficiency of human iPSC generation. , 2008, Cell stem cell.

[147]  Sanjiv S. Gambhir,et al.  Transcriptional and Functional Profiling of Human Embryonic Stem Cell-Derived Cardiomyocytes , 2008, PloS one.

[148]  Andrew D McCulloch,et al.  Substrate stiffness affects the functional maturation of neonatal rat ventricular myocytes. , 2008, Biophysical journal.

[149]  George Q. Daley,et al.  Disease-Specific Induced Pluripotent Stem Cells , 2008, Cell.

[150]  Hynek Wichterle,et al.  Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons , 2008, Science.

[151]  Richard A Young,et al.  Wnt signaling promotes reprogramming of somatic cells to pluripotency. , 2008, Cell stem cell.

[152]  Marius Wernig,et al.  A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types , 2008, Nature Biotechnology.

[153]  Wenjun Guo,et al.  Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds , 2008, Nature Biotechnology.

[154]  Marius Wernig,et al.  Direct Reprogramming of Terminally Differentiated Mature B Lymphocytes to Pluripotency , 2008, Cell.

[155]  Christopher Adams,et al.  Spending on New Drug Development , 2008 .

[156]  B. Priest,et al.  Role of hERG potassium channel assays in drug development , 2008, Channels.

[157]  B. Thiers.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2008 .

[158]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[159]  Jing Liu,et al.  Functional Sarcoplasmic Reticulum for Calcium Handling of Human Embryonic Stem Cell‐Derived Cardiomyocytes: Insights for Driven Maturation , 2007 .

[160]  Rafael Beyar,et al.  Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. , 2007, Journal of the American College of Cardiology.

[161]  Ofer Binah,et al.  Functional and developmental properties of human embryonic stem cells-derived cardiomyocytes. , 2007, Journal of electrocardiology.

[162]  Lila R Collins,et al.  Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts , 2007, Nature Biotechnology.

[163]  Andre Terzic,et al.  Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells , 2007, Nature Clinical Practice Cardiovascular Medicine.

[164]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[165]  J. Kiehn,et al.  The cardiac hERG/IKr potassium channel as pharmacological target: structure, function, regulation, and clinical applications. , 2006, Current pharmaceutical design.

[166]  G. Schatten,et al.  The expression of mitochondrial DNA transcription factors during early cardiomyocyte in vitro differentiation from human embryonic stem cells. , 2005, Cloning and stem cells.

[167]  J. Itskovitz‐Eldor,et al.  Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes. , 2003, American journal of physiology. Heart and circulatory physiology.

[168]  James A Thomson,et al.  Human Embryonic Stem Cells Develop Into Multiple Types of Cardiac Myocytes: Action Potential Characterization , 2003, Circulation research.

[169]  Chun Li Zhang,et al.  Class II Histone Deacetylases Act as Signal-Responsive Repressors of Cardiac Hypertrophy , 2002, Cell.

[170]  Norio Nakatsuji,et al.  Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells , 2001, Current Biology.

[171]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[172]  I. Wilmut,et al.  Viable offspring derived from fetal and adult mammalian cells , 1997, Nature.

[173]  G. Lopaschuk,et al.  Developmental changes in energy substrate use by the heart. , 1992, Cardiovascular research.

[174]  H. Weintraub,et al.  Expression of a single transfected cDNA converts fibroblasts to myoblasts , 1987, Cell.

[175]  M. Kaufman,et al.  Establishment in culture of pluripotential cells from mouse embryos , 1981, Nature.

[176]  J. Gurdon,et al.  The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles. , 1962, Journal of embryology and experimental morphology.

[177]  J. Till,et al.  A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. , 1961, Radiation research.